(Second) #11. made by laith sorour corrected by. date 27/10

Similar documents
AUTONOMIC DRUGS: ADRENOCEPTOR AGONISTS AND SYMPATHOMIMETICS. Lecture 4

Pharmacology of the Sympathetic Nervous System II

Dr. Vishaal Bhat. anti-adrenergic drugs

The adrenergic drugs affect receptors that are stimulated by norepinephrine or epinephrine. Some adrenergic drugs act directly on the adrenergic

a)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline, isoprenaline, dopamine, dobutamine

Prof dr Aleksandar Raskovic DIRECT VASODILATORS

Autonomic Nervous System (ANS) وحدة اليوزبكي Department of Pharmacology- College of Medicine- University of Mosul

BIMM118. Autonomic Nervous System

Adrenergic agonists Sympathomimetic drugs. ANS Pharmacology Lecture 4 Dr. Hiwa K. Saaed College of Pharmacy/University of Sulaimani

Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D.

Systemic Pharmacology Lecture 7: Neuropharmacology

Autonomic Pharmacology

LESSON ASSIGNMENT Given the trade and/or generic name of an adrenergic blocking agent, classify that agent as either an alpha or beta blocker.

Beta 1 Beta blockers A - Propranolol,

ADRENERGIC AGONISTS. Course: Integrated Therapeutics 1. Lecturer: Dr. E. Konorev. Date: September 16, Materials on: Exam #2

Integrated Cardiopulmonary Pharmacology Third Edition

Adrenergic Agonists 1

Adrenergic Receptor Antagonists

Pharmacology Second. - Contraction of detrusor muscle in the bladder.

Adrenoceptor Agonists & Sympathomimetic Drugs

BIOP211 Pharmacology Tutorial Session 10 Drugs affecting the PNS

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)

Adrenergic Receptor as part of ANS

These drugs produce effects similar to the sympathetic nervous system

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

sympathetic nerve impulses endogenous catecholamines beta adrenergic drugs

Autonomic Nervous System (ANS):

Autonomic Nervous System

Adrenoceptor antagonist drugs chapter 10

Autonomic Nervous System. Introduction

Autonomic Nervous System

HYPERTENSION: Sustained elevation of arterial blood pressure above normal o Systolic 140 mm Hg and/or o Diastolic 90 mm Hg

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Drugs acting at the sympathetic nervous system

Pheochromocytoma: Effects of Catecholamines

Adrenergic Agonists. By the end of this lecture, you should be able to: classify adrenergic agonists according to chemical

Ganglionic Blockers. Ganglion- blocking agents competitively block the action of

Autonomic Nervous System Fight Or Flight Vs. Rest And Digest

Pharmacology of the Sympathetic Nervous System I

IV. DIRECT-ACTING ADRENERGIC AGONISTS

Pharmacology of the Sympathetic Nervous System I

Alpha adrenergic blockers

Pharmacology of the Sympathetic Nervous System I

Adrenergic agonists. Chapter 6 pages from (77-82) Done by : & سالي ابورمان. Mohammad Jomaa & Zaid Abadi

Alpha Adrenoceptor Antagonists Beta Adrenoceptor Antagonists Ganglion-Blocking Drugs

Lujain Hamdan. Ayman Musleh & Yahya Salem. Mohammed khatatbeh

PITTMed Cardiology. Pharmacology Modules. Learning Objectives. Site Contents. Fall 2018

The Autonomic Nervous System Introduction. Autonomic Nervous System - Overview

Alpha Receptor Antagonists

Introduction to Autonomic

The Autonomic Nervous System Outline of class lecture for Physiology

sympatholytics sympatholytics sympatholytics

Neuropsychiatry Block

SNS: Pharmacotherapeutics, Medication, and Neuropharmacology

I. BASIC PHARMACOLOGY OF THE ALPHA-RECEPTOR ANTAGONIST DRUGS

PRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets

number Done by Corrected by Doctor Malik

Section 3, Lecture 2

Drugs Affecting The Autonomic Nervous System(ANS)

Pharmacology - Problem Drill 11: Vasoactive Agents

I. OVERVIEW DIRECT. Drugs affecting the autonomic nervous system (ANS) are divided into two groups according to the type of

Angina pectoris due to coronary atherosclerosis : Atenolol is indicated for the long term management of patients with angina pectoris.

Adrenergic Antagonists

BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1

Definition of synapse:

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

B-blockers. Effects not related to Beta-Blockade

Antihypertensive Agents

Vasoactive Medications. Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis

Adrenal Medulla. Amelyn R. Rafael, M.D.

Autonomic Nervous System Dr. Ali Ebneshahidi

I. Neural Control of Involuntary Effectors. Chapter 9. Autonomic Motor Nerves. Autonomic Neurons. Autonomic Ganglia. Autonomic Neurons 9/19/11

REGULATION OF BLOOD PRESSURE

Beta blockers in primary hypertension. Dr. Md. Billal Alam Associate Professor of Medicine DMC

METOTRUST XL-25/50 Metoprolol Succinate Extended-Release Tablets

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

Titrating Critical Care Medications

1. Antihypertensive agents 2. Vasodilators & treatment of angina 3. Drugs used in heart failure 4. Drugs used in arrhythmias

Lab Period: Name: Physiology Chapter 14 Blood Flow and Blood Pressure, Plus Fun Review Study Guide

β adrenergic blockade, a renal perspective Prof S O McLigeyo

NEW ZEALAND DATA SHEET

The Autonomic Nervous System

Constriction and dilatation of blood vessels. Contraction and relaxation of smooth muscle in various organs. Visual accommodation, pupillary size.

Neosynephrine. Name of the Medicine

Antihypertensive drugs SUMMARY Made by: Lama Shatat

Screening and bioassay of Sympatholytics. Dr. Magdy M. Awny Lecture 4

ANTI - ARRHYTHMIC DRUGS

ADRENERGIC RECEPTOR ANTAGONISTS: ALPHA RECEPTOR BLOCKERS

Intravenous Infusions

The Autonomic Nervous

Autonomic Nervous System

Autonomic Nervous System

BIMM118. Autonomic Nervous System

Physiology and Pharmacology

Pharmacology/Therapeutics I Block II Handouts

Autonomic Targets. Review (again) Efferent Peripheral NS: The Autonomic & Somatic Motor Divisions

PHRM20001: Pharmacology - How Drugs Work!

Drug Therapy of Parkinsonism. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

RESPIRATORY PHARMACOLOGY - ASTHMA. Primary Exam Teaching - Westmead ED

Pharmacology/Therapeutics I Block II Handouts

Transcription:

(Second) #11 made by laith sorour corrected by date 27/10

Pre-lecture ( min 3.0) *last lecture we talked about parasympathetic nervous system about cholinergic drugs(agonists) & anti-cholinergic drugs(antagonists) *we call the cells that accept Ach cholinergic cells (min 5.30) -in general adrenergic receptors we have alpha & beta receptors alpha has alpha-1 & 2 beta has 1&2 we talked about them in the last lecture -you should know where each neurotransmitter binds(((ach cholinergic receptors in cholinergic cells and pre-ganglions, noradrenaline and adrenaline in adrenergic receptors))) and the function of each receptor and the agonists and antagonists and how they bind direct & indirect Adrenergic agonist (sympathomimetic or adrenergic drug): (min 7.25) -Agents that mimic actions of sympathetic system & stimulate adrenergic receptors (adrenoceptors) - Adrenergic neurons release norepinephrine as primary neurotransmitter - Adrenergic neurons are found in CNS & sympathetic nervous system SNS (as links between ganglia & effector organs) Classification of adrenergic agonists: **Direct-acting: (8.30) means go direct to the receptor and works as NA & A have two types: 1- Selective (salbutamol, dobutamine) means recognize certain receptor (alpha-1 or 2,beta 1 or 2) is important because can give us certain activity without toxicity(adverse effect) *if affinity of the drug increased for more than one receptor it gives more side effect alpha 1 & 2 are related to each other by shape but some drugs can distinguish between them(selective) but other drugs can t even distinguish between alpha and beta(non-selective) *for example a drug that works on beta-1 & 2(non-selective) can give us a side effect because b-1 increases the heart rate and b-2 dilates airway passages and adrenaline binds t them when someone is running or scared

2- Non-selective (adrenaline, noradrenaline *these are found naturally in the body) *when released in body they bind to all adrenergic receptors *in drugs we only give them in emergencies because it can give high side effects *A works on all receptors\na works on a-1,b-1,a-2 **Indirect-acting: min 9.55 Releasing agents (amphetamine (*CNS stimulator)) makes the releasing of Adrenaline & NA more Uptake inhibitors (cocaine, tricyclic antidepressants) uptake means taking(absorb) the neurotransmitter from pre-synaptic cleft so when we inhibit the uptake more A & NA stays in the cleft near the receptors so we prolong the action MAO Inhibitors mono-amino oxidase recycles neurotransmitters and are used and anti-depressant MAO blockers increases the concentration of neurotransmitters **Mixed-acting(ephedrine, pseudoephedrine) works direct & indirect Actions of adrenergic agonists: min 14.00 -These are mediated through stimulation of alpha, beta & dopaminergic adrenoceptors -All these adrenoceptors are metabotropic receptors (G protein-coupled receptors) *g protein-coupled receptor is 7-helix on membrane which releases second messenger and gives a cascade of actions until the biological effect Inhibitors of noradrenaline pathway in body: min 14.35 Synthesis: metyrosineuseful in treatment phaeochromocytoma Storage: is blocked by reserpine Binding: by alpha & beta-blockers Reuptake:by cocaine & tricyclic antidepressants (TCAs) (imipramine)

Sympathomimetics: They are also classified into: Catecholamines: (adrenaline, NA, dopamine, dobutamine & isoprenaline) *catechol: benzene group + 2 OH Pharmacokinetics: *rapid onset action works fast and eliminated fast *brief duration of action short half-life *not administered orally(used during emergency parenteral) *don t penetrate BBB Poor penetration into CNS * Enzymatic metabolism by MAO & COMT Non-catecholamine: (synthetic alpha-agonists & beta- agonists, e.g. phenylephrine, ephedrine, amphetamine) Pharmacokinetics: * Slower onset & longer duration of action *can be administered orally or via inhalation or parenteral * Less enzymatic degradation because doesn t have catechol group(enzyme goes to catechol group) * More central effects (CNS effects) because when no catechol less OH groups less H-bond more lipophilicity can cross BBB *More the ethyl groups more the affinity so more binding occurs and effect increases so the specificity increases Alpha-adrenoceptors min 21.30 1 present on postsynaptic membrane of organs supplied by sympathetic system 2 present presynaptically on adrenergic nerve terminals & post-synaptically in certain sites *alpha 2 makes balance by negative feedback inhibition Presynaptic 2 are autoregulatory; controlling release of NA from nerve endings. 2 stimulation inhibits NA release high NA conc. Inhibits its release alpha2 reveres the sympathetic action although it s a receptor for it because it is regulatory Alpha1-Adrenoceptors : Vascular smooth M Vasoconstriction Radial M. of iris Mydriasis Bladder sphincter Contraction

Intestine sphincter Contraction Male sex organs Ejaculation Inhibits entry of K into cells Hyperkalemia(high K in blood) Increase peripheral vascular resistance (blood moves in dilated veins easier) if it is very high makes hypertension Alpha2-adrenoceptors: Presynaptic Inhibits NA release Platelets Enhances aggregation Islet cells Inhibits insulin release of pancreas *alpha2 blockers increase insulin alpha-stimulants: Pressor agents: - Phenylephrine Mucosal decongestants: - Pseudoephedrine, Oxymetazoline Alpha 2-agonists: - Clonidine & alpha-methyldopa 1- Pressor agents : These are non-catecholamines that increase peripheral vascular resistance (PVR) & arterial blood pressure (both SBP & DBP) Heart rate may decrease due to reflex vagal stimulation secondary to increase in ABP They reduce renal blood flow (RBF) & splanchnic blood flow due to 1-vasoconstriction **Phenylephrine: -* Is a direct acting, synthetic adrenergic drug -* It has predominantly direct 1-agonist effect, a vasoconstrictor & It is used as: - Pressor agent - Nasal decongestant agent (makes vasoconstriction for nasal vessels) - Mydriatic agent (makes the iris wider) - Vasoconstrictor agent with local anesthetics (LA) *local anesthesia dilates the vessels so the absorption increases this leads to short anesthesia so we give a phenylephrine so it constricts the vessels and make longer effect of anesthesia 2-Mucosal decongestants: (Pseudoephedrine, Oxymetazoline) min 29.00 )التهاب الجيوب( -* Useful in allergic rhinitis, common cold & sinusitis

-* Oxymetazoline is used in Ophthalmic drops for relief of redness of eye associated with swimming, colds or contact lens *if the face is red means its vasodilated \blue constricted ** Avoid: Prolonged use (rebound congestion means when we stop taking the drug the problem returns so we give it 3 days and stop) In hypertensive patients in hypertension the vessels are already constricted Children below 2 years of age Therapy with MAOI or with tricyclic AD those drugs increase the conc. Of neurotransmitters so when I give an agonist overdose happens and leads to shock 3. Alpha 2-agonists (clonidine & alpha-methyldopa) -*centrally acting antihypertensive drugs: clonidine & alpha-methyldopa (Aldomet) -*these act acentrally to produce inhibition of sympathetic vasomotor centers, decreasing sympathetic outflow to the periphery -*they are rarely used because of risk of rebound hypertension on withdrawal of therapy Adrenergic Antagonist (blockers or sympatholytic agents): 32.00 -* These drugs act by either reversibly or irreversibly attaching to the receptor, thus preventing its activation by endogenous catecholamines -* They are classified according to their relative affinities for α or β receptors: - β-blockers - α-blockers Beta-adrenergic blocking agents *are found everywhere but B1 majorly concentrated in heart\b2 majorly concentrated in lungs They are divided into: -*Non-selective: act at both β1 and β2 receptors -*Cardioselective: block β1 receptors The names of all β-blockers end in -olol except for labetalol and carvedilol Therapeutic use: min 34.00 - Hypertension (HTN) (the drug either dilate the vessels or decrease heart rate) -Angina -Cardiac arrhythmias - Myocardial infarction (MI) - Congestive heart failure (CHF) - Hyperthyroidism (happens because of very active heart work) -Glaucoma *anti-adrenergic drugs are almost same as cholinergic drugs

- Prophylaxis of migraine headaches *one of the reasons of headache is vasodilation so beta-blockers constricts it A. Propranolol: { 38.00 - Inderal, Indicardin -A nonselective β antagonist -is the prototype β-adrenergic antagonist and blocks both β1 and β2 receptors actions: A. Cardiovascular: - Negative inotropic & chronotropic effects (decrease cardiac output, bradycardia, decrease oxygen consumption) B. Peripheral vasoconstriction: - Reduction in cardiac output leads to decreased blood pressure. This hypotension triggers a reflex peripheral vasoconstriction C. Bronchoconstriction D. Increased Na+ retention ( E. Hypoglycemia Therapeutic effects: 1. Hypertension 2. Migraine (prophylaxis) 3. Hyperthyroidism 4. Chronic stable angina (not for acute attacks) 5. Myocardial infarction: (protect form second attack, reduce infarct size, sudden arrhythmic deaths) 6. Anxiety 7. Essential tremor Adverse effects: - Bronchoconstriction - Cardiac arrhythmias (sudden withdrawal) because of reflux tachycardia also reflux peripheral vasoconstriction happens -Sexual impairment becaue less blood flow - Hypoglycemia } B. Timolol, Nadolol - Nonselective β antagonists -Are more potent than propranolol - Nadolol has long duration of action (14-24 hrs) - Timolol is used topically in treatment of chronic open-angle glaucoma. It reduces production of

aqueous humor by ciliary body - Occasionally, for systemic treatment of hypertension(in pprogressed situations because nonselective) C. Selective B1 antagonists : - Acebutolol, atenolol (hypoten, tenormin), metoprolol, esmolol - Cardioselective β-blockers - Are useful in hypertensive patients - Are useful in diabetic hypertensive patients - Have less effect on peripheral vascular β2 receptors, coldness of extremities, a common side effect of β-blocker therapy, is less frequent D. Antagonists of a- & b- adrenoceptors : { -Labetalol & carvedilol -Are reversible β-blockers with concurrent α1-blocking actions that produce peripheral vasodilation, thereby reducing blood pressure -Carvedilol also decreases lipid peroxidation and vascular wall thickening, effects that have benefit in heart failure. Labetalol: -Labetalol is useful for treating the elderly or black hypertensive patient -Labetalol is employed as an alternative to methyldopa in treatment of pregnancy-induced hypertension -I.V labetalol is used to treat HTN emergencies, because it can rapidly lower blood pressure Adverse effects: - Orthostatic hypotension and dizziness are associated with α1 blockade *orthostatic according to standing pose pressure to position (higher to slower): sleeping sitting standing Alpha-adrenergic blocking agents: Drugs that block α-adrenoceptors profoundly affect blood pressure alpha 1 blockers: Prazosin, terazosin, doxazosin, alfuzosin, and tamsulosin Are selective competitive blockers of α1 receptor They decrease peripheral vascular resistance (PVR) & lower arterial blood pressure (ABP) by causing relaxation of both arterial and venous smooth muscle -smooth muscles are involuntary so inhibition of receptor makes dilation (relaxation)

Therapeutic uses : Treatment of Hypertension Benign prostatic hypertrophy (BPH) Prazosin, terazosin, doxazosin (alphapress, cardura) are useful in the treatment of hypertension The first dose of these drugs produces an exaggerated orthostatic hypotensive response that can result in syncope (fainting) This action, termed a first-dose effect, may be minimized by reducing dose and by giving drug at bedtime Tamsulosin (omnic) and alfuzosin (xatral) are indicated for the treatment of benign prostatic hypertrophy (also known as benign prostatic hyperplasia or BPH) have been used as an alternative to surgery in patients with symptomatic BPH. Blockade of the α receptors decreases tone in the smooth muscle of the bladder neck and prostate and improves urine flow Tamsulosinis a more potent inhibitor of α1a receptors found on smooth muscle of prostate ** Adverse effects: Dizziness, a lack of energy, nasal congestion, headache, drowsiness, and orthostatic hypotension -the more the pressure decreases the more fatigue one is alpha1- & alpha2- blockers : Phenoxybenzamine Nonselective, block both α1-postsynaptic and α2-presynaptic receptors Is used in treatment of pheochromocytoma, a catecholamine-secreting tumor of cells derived from adrenal medulla Adverse effects: postural hypotension, nasal stuffiness, nausea, vomiting, inhibit ejaculation *if someone have ejaculation problems first thing you ask does he take anti-hypertensive drugs *For tables and pictures go back to slides *next week only pharma *the week next the doctor is flying so we will take micro Good luck ))